| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919208 | Radiotherapy and Oncology | 2013 | 7 Pages |
Abstract
Our data show potent antisurvival and radiosensitizing effects of the novel HDAC inhibitor NDACI054 encouraging further preclinical examinations on this compound for future clinical use.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Stephanie Hehlgans, Katja Storch, Inga Lange, Nils Cordes,